1 Min Read
May 10 (Reuters) - Enzymotec Ltd:
* Enzymotec Ltd - on May 5, 2017, FDA issued import alert that included co's vayarol, vayarin and vayacog products
* Enzymotec Ltd - co's vayarol, vayarin and vayacog products, are labeled and sold as "medical foods" in the United States
* Enzymotec - became aware following facility inspection held during aug 2016 at facilities of supplier to co such supplier received warning letter from FDA
* Enzymotec Ltd - warning letter referenced vayarin as well as products of other manufacturers, alleging that vayarin is a "new drug"
* Enzymotec Ltd - is prepared to defend its position that the products are properly sold as "medical foods" and are not subject to the drug provisions Source text: (bit.ly/2qZIP3F) Further company coverage: